Browsing: Zepbound

As a port strike stretching from New England to Texas halted nearly half of all trade coming into the U.S.,…

By Patrick Wingrove (Reuters) -Eli Lilly said it has begun selling vials of the smallest, starter dose of its popular…

Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly…

Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by…

By Patrick Wingrove (Reuters) – Eli Lilly (NYSE:) on Friday said its popular weight-loss drug Zepbound helped resolve moderate to…

By Bhanvi Satija and Sriparna Roy (Reuters) – Evidence that weight-loss drugs like Novo Nordisk (NYSE:)’s Wegovy and Eli Lilly…

The market for weight-loss drugs such as Ozempic and Wegovy will keep surging due to new products including Eli Lilly’s…

Eli Lilly on Tuesday reported first-quarter adjusted profit that topped Wall Street’s expectations and hiked its full-year guidance on strong…